Feasibility of Cetuximab (ERBITUX) Associated With Concomitant Radio-chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer: a Phase II, Randomised Study.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel; Etoposide; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 18 Oct 2012 Status changed from recruiting to completed.
- 02 Oct 2012 Final results presented at the 37th Congress of the European Society for Medical Oncology.
- 21 Jun 2012 Additional company (Merck KGaA) added in association as reported by European Clinical Trials Database.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History